<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
and Rule 13a-17 or 15d-17 thereunder
RoTech Medical Corporation
- --------------------------------------------------------------------------------
(Exact name of issuer as specified in charter)
4506 L. B. McLeod Road, Suite F. Orlando, FL 32811
- --------------------------------------------------------------------------------
(Address of principal executive offices)
Issuer's telephone number, including area code (407) 841-2115
----------------------------------
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase of decrease) of 5% or more in the number of shares
outstanding:
1. Title of security Common Stock, par value $.0002
-----------------------------------------------------------
2. Number of shares outstanding before the change 11,367,000
------------------------------
3. Number of shares outstanding after the change 24,794,180
------------------------------
4. Effective date of change April 30, 1996
----------------------------------------------------
5. Method of change:
Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.)
--------------
Stock Dividend
----------------------------------------------------------------------------
Give brief description of transaction Issuer has declared a 100% stock
---------------------------------------
dividend payable to holders of record as of April 30, 1996, which dividend
----------------------------------------------------------------------------
is to be distributed on May 21, 1996.
----------------------------------------------------------------------------
----------------------------------------------------------------------------
II. CHANGE IN NAME OF ISSUER
1. Name prior to change
-------------------------------------------------------
2. Name after change
----------------------------------------------------------
3. Effective date of charter amendment changing name
--------------------------
4. Date of shareholder approval of change, if required
------------------------
Ro-Tech Medical Corporation
Date May 9, 1996 By: /s/ Rebecca R. Irish
------------------------------ -----------------------------------
Rebecca R. Irish, Treasurer and
Chief Financial Officer
